Vincent J. Milano

2019

In 2019, Vincent J. Milano earned a total compensation of $1.3M as President and Chief Executive Officer at Idera Pharmaceuticals, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$315,000
Option Awards$279,160
Salary$600,000
Stock Awards$105,975
Other$37,082
Total$1,337,217

Milano received $600K in salary, accounting for 45% of the total pay in 2019.

Milano also received $315K in non-equity incentive plan, $279.2K in option awards, $106K in stock awards and $37.1K in other compensation.

Rankings

In 2019, Vincent J. Milano's compensation ranked 7,892nd out of 13,971 executives tracked by ExecPay. In other words, Milano earned more than 43.5% of executives.

ClassificationRankingPercentile
All
7,892
out of 13,971
44th
Division
Manufacturing
3,111
out of 5,701
45th
Major group
Chemicals And Allied Products
1,175
out of 2,200
47th
Industry group
Drugs
1,004
out of 1,886
47th
Industry
Biological Products, Except Diagnostic Substances
229
out of 389
41st

Pay ratio

Vincent J. Milano's Pay$1,337,217
Median Employee's Pay$278,816
Pay Ratio

5

to 1

In 2019, the annual total compensation of Vincent J. Milano was $1,337,217.

The annual total compensation of the median employee at Idera Pharmaceuticals was $278,816.

The ratio of Vincent J. Milano's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 6, 2020.

Milano's colleagues

We found four more compensation records of executives who worked with Vincent J. Milano at Idera Pharmaceuticals in 2019.

2019

Jonathan Yingling

Idera Pharmaceuticals

Chief Scientific Officer

2019

R Fletcher

Idera Pharmaceuticals

Senior Vice President, Business Development and Strategy

2019

Bryant Lim

Idera Pharmaceuticals

General Counsel

2019

John Kirby

Idera Pharmaceuticals

Chief Financial Officer

News

You may also like